About TECHIMMUNE LLC
TechImmune, Inc. was founded in 2021 with the mission to develop novel strategies against Coronaviruses using a T cell antigen platform technology licensed from the University of California. The company focuses on creating immunotherapies for acute and Long COVID.
Development of T-cell antigen-based immunotherapiesResearch and development of antiviral immune therapies for acute and Long COVIDLeveraging conserved non-spike viral antigens to drive antiviral T cell responses
Is this your company?
Claim TECHIMMUNE LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim TECHIMMUNE LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.